Marco Racchi spends much of his time researching Biochemistry, Amyloid precursor protein, Endocrinology, Internal medicine and Alzheimer's disease. The concepts of his Amyloid precursor protein study are interwoven with issues in Acetylcholinesterase, Tacrine, Neuroscience and Metabolism. His study in Endocrinology is interdisciplinary in nature, drawing from both Fibroblast and Huntingtin, Polyglutamine tract.
His Alzheimer's disease study combines topics from a wide range of disciplines, such as Transmembrane protein, Cell biology, Cortex, Notch signaling pathway and Degenerative disease. Marco Racchi has researched COS cells in several fields, including Cell, Cell membrane, Reverse cholesterol transport, Lipoprotein and Intracellular. His work in Disease covers topics such as Cancer which are related to areas like Signal transduction.
Marco Racchi focuses on Internal medicine, Endocrinology, Amyloid precursor protein, Disease and Signal transduction. His research integrates issues of Cell culture and Cell in his study of Internal medicine. His Endocrinology research incorporates themes from Fibroblast, Protein kinase C, Cytokine and Degenerative disease.
His Amyloid precursor protein study integrates concerns from other disciplines, such as Biochemistry, Neuroscience, Cholinergic and Protein kinase A. His Disease study incorporates themes from Peripheral, Pathophysiology, Immunology and Oncology. The study incorporates disciplines such as Receptor, Regulation of gene expression, Neurodegeneration and Kinase in addition to Signal transduction.
His scientific interests lie mostly in Receptor for activated C kinase 1, Signal transduction, Neuroscience, Cell biology and Immune system. His Receptor for activated C kinase 1 research is multidisciplinary, incorporating perspectives in Endocrinology, Internal medicine, Glucocorticoid receptor and Downregulation and upregulation. The Glucocorticoid research Marco Racchi does as part of his general Endocrinology study is frequently linked to other disciplines of science, such as Dehydroepiandrosterone, therefore creating a link between diverse domains of science.
His Internal medicine research incorporates themes from Depression and Mood. His Neuroscience study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Neurodegeneration, Disease and Amyloid precursor protein. His work in Amyloid precursor protein addresses subjects such as Inverse Association, which are connected to disciplines such as Cancer.
Marco Racchi mainly focuses on Pharmacology, Disease, Endocrinology, Dehydroepiandrosterone and Internal medicine. He interconnects IC50, Neurodegeneration, Enzyme and Amyloid in the investigation of issues within Pharmacology. The concepts of his Neurodegeneration study are interwoven with issues in Curcumin, Intensive care medicine and Dementia, Cognitive decline.
His Disease research integrates issues from Gene, Cytotoxic T cell, Free radical scavenger, Neuroscience and Peptide. Marco Racchi studies Glucocorticoid receptor, a branch of Endocrinology. His studies deal with areas such as Signal transduction, Gene knockdown and Downregulation and upregulation as well as Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
Michele Catanzaro;Francesca Fagiani;Francesca Fagiani;Marco Racchi;Emanuela Corsini.
Signal Transduction and Targeted Therapy (2020)
Acetylcholinesterase inhibitors: novel activities of old molecules
Marco Racchi;Michela Mazzucchelli;Emanuela Porrello;Cristina Lanni.
Pharmacological Research (2004)
Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease
Marta Valenza;Dorotea Rigamonti;Donato Goffredo;Chiara Zuccato.
The Journal of Neuroscience (2005)
Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway
Daniela C. Solano;Marita Sironi;Claudia Bonfini;S. Bruno Solerte.
The FASEB Journal (2000)
Cognition enhancers between treating and doping the mind.
Cristina Lanni;Silvia C. Lenzken;Alessia Pascale;Igor Del Vecchio.
Pharmacological Research (2008)
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content
Marco Racchi;Roberta Baetta;Nathalie Salvietti;Paola Ianna.
Biochemical Journal (1997)
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
L. Gasparini;M. Racchi;G. Binetti;M. Trabucchi.
The FASEB Journal (1998)
In vitro and ex vivo antihydroxyl radical activity of green and roasted coffee.
Maria Daglia;Marco Racchi;Adele Papetti;Cristina Lanni.
Journal of Agricultural and Food Chemistry (2004)
CALCIUM RESPONSES IN FIBROBLASTS FROM ASYMPTOMATIC MEMBERS OF ALZHEIMER'S DISEASE FAMILIES
René Etcheberrigaray;Naohide Hirashima;Linda Nee;José Prince.
Neurobiology of Disease (1998)
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease.
Maria Luisa Brandi;Lucia Becherini;Luigi Gennari;Marco Racchi.
Biochemical and Biophysical Research Communications (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: